What is NDC 69489-411?

69489-411 is the product NDC for Qbrexza (glycopyrronium), Glycopyrronium tosylate 2.4 g/100g cloth, listed with the FDA by Journey Medical Corporation. It has 2 package NDCs, shown above in 10- and 11-digit form.

Journey Medical Corporation, NDC labeler code 69489. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Qbrexza?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Qbrexza NDC 69489-411 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)69489-411Labeler and product segments. Claims need a package NDC.

Product NDC at billing width69489-0411Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
69489-411-05	69489041105	5 POUCH in 1 CARTON (69489-411-05) / 2.8 g in 1 POUCH (69489-411-51)Marketed from Dec 3, 2021 · Sample package
69489-411-30	69489041130	30 POUCH in 1 CARTON (69489-411-30) / 2.8 g in 1 POUCH (69489-411-01)Marketed from Dec 3, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Qbrexza
Generic name (nonproprietary): glycopyrronium
Active ingredients: Glycopyrronium tosylate — 2.4 g/100g
Dosage form: Cloth
Route: Topical
Labeler: Journey Medical CorporationNDC labeler code 69489
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 210361
Marketing start: Jun 28, 2018
Listing expires: Dec 31, 2027
Other FDA classes: Cholinergic Antagonists (Mechanism)Cholinergic Muscarinic Antagonists (Mechanism)
Identifiers: Product ID 69489-411_52537ea0-9410-1691-e063-6394a90a9468SPL ID 52537ea0-9410-1691-e063-6394a90a9468SPL set ID 5b372650-e56e-47a5-93e2-c0c292017059RxCUI 2054118, 2054120UNII 1PVF6JLU7B
Pharmacologic class: Anticholinergic; Cholinergic Muscarinic Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N469489041105 followed by a unit qualifier and the quantity

Package 69489-0411-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 21, 2026.

Indications (excerpt from the label)

Qbrexza is indicated for topical treatment of primary axillary hyperhidrosis in adult and pediatric patients 9 years of age and older. Qbrexza is an anticholinergic indicated for topical treatment of primary axillary hyperhidrosis in adults and pediatric patients 9 years of age and older ( 1 ).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 69489-411

What is NDC 69489-411?: 69489-411 is the product NDC for Qbrexza (glycopyrronium), Glycopyrronium tosylate 2.4 g/100g cloth, listed with the FDA by Journey Medical Corporation. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Qbrexza (Glycopyrronium).
What is the active ingredient?: Glycopyrronium tosylate.
Who is the labeler?: Journey Medical Corporation, NDC labeler code 69489. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Qbrexza?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Qbrexza (Glycopyrronium) NDC 69489-411